Loading...

Performant Healthcare, Inc.

PHLTNASDAQ
Technology
Information Technology Services
$7.62
$0.005(0.07%)

Performant Healthcare, Inc. (PHLT) Financial Performance & Income Statement Overview

Review Performant Healthcare, Inc. (PHLT) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
8.12%
8.12%
Operating Income Growth
-55.03%
55.03%
Net Income Growth
-31.60%
31.60%
Operating Cash Flow Growth
60.05%
60.05%
Operating Margin
-0.03%
0.03%
Gross Margin
49.68%
49.68%
Net Profit Margin
-0.64%
0.64%
ROE
-1.13%
1.13%
ROIC
-0.05%
0.05%

Performant Healthcare, Inc. (PHLT) Income Statement & Financial Overview

View the income breakdown for Performant Healthcare, Inc. PHLT across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$33.27M$34.77M$31.52M$29.36M
Cost of Revenue$33.12M$35.45M$33.67M$0.00
Gross Profit$149999.00-$689000.00-$2.15M$29.36M
Gross Profit Ratio$0.005-$0.02-$0.07$1.00
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$25.36M$26.71M$25.97M$24.53M
Operating Expenses$33.12M$35.45M$33.67M$32.10M
Total Costs & Expenses$33.12M$35.45M$33.67M$32.10M
Interest Income$98000.00$99000.00$93000.00$61000.00
Interest Expense$289000.00$306000.00$313000.00$300000.00
Depreciation & Amortization$1.60M$1.38M$2.02M$2.04M
EBITDA$1.85M$785000.00-$41000.00-$645000.00
EBITDA Ratio$0.06$0.02-$0.001-$0.02
Operating Income$150000.00-$689000.00-$2.15M-$2.74M
Operating Income Ratio$0.005-$0.02-$0.07-$0.09
Other Income/Expenses (Net)-$191000.00-$207000.00-$220000.00-$239000.00
Income Before Tax-$41000.00-$896000.00-$2.37M-$2.98M
Income Before Tax Ratio-$0.001-$0.03-$0.08-$0.10
Income Tax Expense$40000.00-$398000.00$15000.00$16000.00
Net Income-$81000.00-$498000.00-$2.38M-$3.00M
Net Income Ratio-$0.002-$0.01-$0.08-$0.10
EPS-$0.001-$0.006-$0.03-$0.04
Diluted EPS-$0.001-$0.006-$0.03-$0.04
Weighted Avg Shares Outstanding$78.31M$77.75M$77.75M$76.97M
Weighted Avg Shares Outstanding (Diluted)$78.31M$77.75M$77.75M$76.97M

Financial performance has remained strong, with revenue growing from $29.36M in Q2 2024 to $33.27M in Q1 2025. Gross profit continued to perform well, with margins at 1% in the latest quarter. Operating income reached $150000.00 in Q1 2025, holding a steady 1% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.85M. Net income rose to -$81000.00, keeping EPS at -$0.001. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;